Home/All Molecules/Levetiracetam

Levetiracetam Range

Comprehensive Levetiracetam portfolio for Franchise & Manufacturing.

Category
levetiracetam
Total Formulations
10
Available Forms
Infusion, Injection, Syrup, Tablets

Expand Your Business with Our Multiple Divisions


Browse Levetiracetam portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Levetiracetam batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Levetiracetam PCD Pharma Franchise

Levetiracetam PCD Pharma Franchise Company

Cafoli Lifecare is a trusted Levetiracetam PCD pharma franchise company offering 10 formulations across tablets, syrups, injection and infusion. Manufactured under WHO-GMP certified standards, this range gives franchise partners a broad-spectrum antiepileptic covering paediatric to critical-care needs.

What is Levetiracetam?

Levetiracetam is a broad-spectrum antiepileptic drug with a novel mechanism. It binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release and reducing abnormal, synchronised neuronal firing. Unlike older agents it has little effect on liver enzymes, giving it a favourable, low-interaction profile and predictable pharmacokinetics. Learn more on PubChem.

Therapeutic Applications of Levetiracetam

Levetiracetam is used for partial-onset (focal) seizures, myoclonic seizures in juvenile myoclonic epilepsy, and primary generalised tonic-clonic seizures, as monotherapy or adjunctive therapy; the IV form is valuable in status epilepticus and when oral dosing is not possible. It is prescribed by neurologists, paediatric neurologists and intensivists.

Why Levetiracetam is a High-Potential Molecule for Distributors

Levetiracetam has become one of the most widely used first-choice antiepileptics because of its broad spectrum, ease of dosing and minimal drug interactions, which suit patients on multiple medications. Its full range of tablet, syrup, injection and infusion forms supports every setting from paediatric outpatient to ICU, giving distributors a high-volume, long-term-therapy neurology molecule with dependable demand.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers exclusive district-wise monopoly rights, WHO-GMP certified and DCGI-approved formulations, attractive promotional inputs and marketing support, and the reliability of a network trusted by 1000+ franchise partners across India.

References

  1. PubChem – Levetiracetam Compound Summary, U.S. National Library of Medicine
  2. PubMed – Clinical literature on Levetiracetam

Aceclofenac in Modern Clinical Practice

Our formulations of Levetiracetam find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Levetiracetam in PCD Franchise

Start Your Levetiracetam Franchise with Cafoli Lifecare. Partner with us for quality Levetiracetam formulations backed by monopoly rights and complete promotional support. Call 9518447302 or email info@cafoli.in to book your territory today.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 10 Levetiracetam formulations across tablets, syrups, injection and infusion for franchise and manufacturing partners.

Yes. Cafoli Lifecare grants exclusive district-wise monopoly rights so your neurology territory is protected from internal competition.

It is prescribed by neurologists, paediatric neurologists and intensivists for focal, myoclonic and generalised seizures and status epilepticus.

Its broad spectrum, easy dosing and minimal drug interactions make it a first-choice antiepileptic across all ages and settings, driving strong long-term demand.

A valid Drug License and GST registration are required. On submission, Cafoli Lifecare issues your monopoly agreement and promotional inputs.